MAPT and Alzheimer disease: The use of second-generation Tau tracers has allowed to confirm that AD patients exhibit a higher tracer signal in medial temporal areas as well as throughout the posterior cingulate, lateral parietal and occipital lobes and prefrontal cortex [49].